Galileo Research Facts No. 150: Can exhaustive Galileo Therapy be used safely even in heart transplant patients?
18 Sep
GRFS, Therapy

Galileo Research Facts No. 150: Can exhaustive Galileo Therapy be used safely even in heart transplant patients?

Posted by
This study reported the effects of Galileo Therapy on cardiovascular parameters in patients after heart trans-plant (4 months post and longer) (26Hz, pos. 1.5, 70° squat). All patients received additional cardiovascular exercises on a cycling ergometers (av. Heart-rate 118Hz). The results showed that exhaustive Galileo Therapy even at higher frequencies (26Hz) has only a moderate effect on the cardiovascular system.
Continue reading
Galileo Research Facts No. 144: Can 3 weeks of Galileo Therapy improve balance in COPD patients?
18 Sep
GRFS, Therapy

Galileo Research Facts No. 144: Can 3 weeks of Galileo Therapy improve balance in COPD patients?

Posted by
This study documented the effects of Galileo Therapy on Balance and muscle function in COPD patients. Both groups received endurance training (15 min.) + strength training (50 Min) 5/week, as well as additional 4*2 min. squatting exercises with or without Galileo (24-26Hz, pos. 2.5, 3/week, 3 weeks). The Galileo group showed significantly higher effects on Balance with improvements of up to 28% (e.g. semi-tandem stance, eyes closed)...
Continue reading
Galileo Research Facts No. 142: Can Galileo Therapy improve bone parameters in Pompe disease patients?
18 Sep
GRFS, Therapy

Galileo Research Facts No. 142: Can Galileo Therapy improve bone parameters in Pompe disease patients?

Posted by
This pilot study documented effects of Galileo Therapy on bone architecture in patients with pope disease (20Hz, pos. 2, 4 Min., 3/week, 15 weeks). One of the patients was ambulatory the other wheel-chair bound. Both patients showed improvements, however the effects where much more pronounced in the wheel-chair bound patient with improvements of trabecular bone density of 12% and in trabecular number of 23%...
Continue reading
Galileo Research Facts No. 140: Can Galileo Therapy increase muscle force and decrease fall-risk in young obese?
18 Sep
GRFS, Therapy

Galileo Research Facts No. 140: Can Galileo Therapy increase muscle force and decrease fall-risk in young obese?

Posted by
This study investigated the effects of Galileo Therapy on muscle force and fall-risk in young obese patients (26Hz, pos. 2, 20° squat, 5x60s., 3/week, 6 weeks). The control group performed identical exercises without Galileo. The Galileo group showed significantly higher effects than the control group for example on muscle strength (extensor torque increase by +6%) as well as reduction of fall-risk and fall-rate by -68%...
Continue reading
Galileo Research Facts No. 136: Can Galileo Therapy improve quality of life (QOL) in Fibromyalgia patients?
18 Sep
GRFS, Therapy

Galileo Research Facts No. 136: Can Galileo Therapy improve quality of life (QOL) in Fibromyalgia patients?

Posted by
This study reported the effects of Galileo Therapy on health related quality of life (HRQOL) in Fibromyalgia patients (12.5Hz, 6x30-60s., 3/week, 12 weeks). Both groups received additional standard therapy, the Galileo group additional Galileo Therapy. While the control groups showed a decrease in health related quality of life (FIQ) by up to 7% the Galileo group showed an improvement with an over-all difference of up to 11%...
Continue reading
Galileo Research Facts No. 134: Can Galileo Therapy in Ataxia patients improve blood-flow and muscle activation?
18 Sep
GRFS, Therapy

Galileo Research Facts No. 134: Can Galileo Therapy in Ataxia patients improve blood-flow and muscle activation?

Posted by
This study investigated the immediate effects of Galileo Therapy with different frequencies and durations on muscle activation (EMG) and blood-flow (Galileo Delta, 45° tilt, 60° knee flexion, pos. 2.5, 10, 20, 30Hz, 1*3 vs. 3*1 min., 6 session/2 weeks). High frequencies (30Hz) during Galileo Delta Therapy showed higher effects on blood-flow (+33%), exertion (96%) and EMG Frequency (55%) compared to lower frequencies (10Hz)...
Continue reading
Galileo Research Facts No. 132: Can Galileo Therapy increase muscle power and decrease fall risk in Multiple Sclerosis (MS) patients?
18 Sep
GRFS, Therapy

Galileo Research Facts No. 132: Can Galileo Therapy increase muscle power and decrease fall risk in Multiple Sclerosis (MS) patients?

Posted by
This pilot study reported the effects of Galileo Therapy on fall risk and muscle power in MS (multiple sclerosis) patients (20Hz, pos. 1.5, slightly flexed legs (20°), 5*1 min., 3/week, 8 weeks). Just 5 minutes Galileo Therapy 3 times per week showed decreased fall-risk and significantly improved balance (+12%), muscle function and muscle Power (+12%) as well as knee torque at flexor (+12) and extensor (15%)...
Continue reading
Galileo Research Facts No. 128: Can Galileo Therapy improve Gait Parameters in Stroke patients significantly?
18 Sep
GRFS, Therapy

Galileo Research Facts No. 128: Can Galileo Therapy improve Gait Parameters in Stroke patients significantly?

Posted by
This study investigated the effects of Galileo Therapy in combination with treadmill therapy on gait parameters in stroke patients (20-30Hz, 4*45sec., 3/week, 6 weeks, 6 different exercises). The control group received treadmill therapy without Galileo (20Min./session). In all reported functional outcome parameters the effects in combination with Galileo Therapy were up to factor 3.25 (+225%) higher than treadmill therapy only...
Continue reading
Galileo Research Facts No. 126: Can Galileo Therapy improve muscle function and muscle cross-section in Cystic Fibrosis?
18 Sep
GRFS, Therapy

Galileo Research Facts No. 126: Can Galileo Therapy improve muscle function and muscle cross-section in Cystic Fibrosis?

Posted by
This study investigated the effects of 6 months of Galileo Therapy on muscle function and cross-section in Cystic Fibrosis patients (12Hz, 6min., 5/week (flexibility) + 26Hz 3/week (muscle power)). The Galileo group showed in average an improvement in muscle cross-section (+5,5%), muscle function (jump height +6,1%) as well as movement efficiency (decrease of used muscle force -4,3% but increase in muscle power +4,7%)...
Continue reading
Galileo Research Facts No. 124: Can Galileo Therapy improve muscle force and endurance in COPD-patients?
18 Sep
GRFS, Therapy

Galileo Research Facts No. 124: Can Galileo Therapy improve muscle force and endurance in COPD-patients?

Posted by
This study investigated the effects of Galileo Therapy in COPD patients. (6-24Hz, 3*3 min., progressive, 150° squat, pos.2-3, 2/week, 3 months, +15 min. warmup+cool-down). The control group received Calisthenics exercises (2*30 min./week). While the control group did not show any significant changes that Galileo group showed highly significant improvements in muscle force and endurance with up to +38% (leg press, 1RM)...
Continue reading